Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361186
Status:
COMPLETED
Last Update Posted:
2024-04-11
First Post:
2024-03-12
Brief Title:
Proximod Pharmacokinetics In Healthy Subjects
Sponsor:
Longevity Inc
Organization:
Longevity Inc
Study Overview
Official Title:
A Single-center Randomized Double-blind Placebo-controlled Phase I Study to Evaluate the Tolerability Pharmacokinetics and Pharmacodynamics of Proximod in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the tolerability pharmacokinetics and pharmacodynamics of Proximod in healthy subjects The main questions it arms to answer are
1 to evaluate the safety and tolerance of Proximod in healthy subjects after single or repeated doses
2 to learn the pharmacodynamics of Proximod in healthy subjects after single or repeated doses
3 to evaluation of the effect of food on the pharmacokinetics of Proximod in healthy subjects Participants will receive test tablets or placebo at the indicated date and collect blood samples
1 to evaluate the safety and tolerance of Proximod in healthy subjects after single or repeated doses
2 to learn the pharmacodynamics of Proximod in healthy subjects after single or repeated doses
3 to evaluation of the effect of food on the pharmacokinetics of Proximod in healthy subjects Participants will receive test tablets or placebo at the indicated date and collect blood samples
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None